Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 769,362
  • Shares Outstanding, K 135,690
  • Annual Sales, $ 51,330 K
  • Annual Income, $ -60,590 K
  • 36-Month Beta 1.48
  • Price/Sales 15.20
  • Price/Cash Flow N/A
  • Price/Book 8.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.10
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.96 +14.31%
on 11/15/18
5.82 -2.58%
on 12/12/18
+0.37 (+6.98%)
since 11/13/18
3-Month
4.96 +14.31%
on 11/15/18
7.54 -24.80%
on 09/25/18
-1.67 (-22.75%)
since 09/13/18
52-Week
3.35 +69.25%
on 12/29/17
8.05 -29.57%
on 08/03/18
+1.87 (+49.21%)
since 12/13/17

Most Recent Stories

More News
Best Relative Performance in the Health Care Supplies Industry Detected in Shares of Cerus Corp (CERS , NEOG , XRAY , WST , QDEL )

We looked at the Health Care Supplies industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

XRAY : 37.72 (-1.05%)
NEOG : 63.37 (-2.13%)
CERS : 5.67 (-1.39%)
Best Relative Performance in the Health Care Supplies Industry Detected in Shares of Cooper Cos Inc (COO , ALGN , CERS , STAA , HAE )

We looked at the Health Care Supplies industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

COO : 256.88 (+0.84%)
ALGN : 217.23 (-0.94%)
CERS : 5.67 (-1.39%)
American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets

Cerus Corporation (Nasdaq:CERS) announced today that the American Red Cross has received approval by the U.S. Food and Drug Administration (FDA) for their first biologics license application...

CERS : 5.67 (-1.39%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 7.75 (-1.02%)
EPAY : 50.40 (-0.61%)
EXAS : 67.85 (-5.49%)
WYNN : 108.11 (-1.18%)
HMSY : 34.28 (-2.17%)
GLT : 11.01 (-2.65%)
MHK : 118.20 (-0.60%)
BBW : 4.72 (-5.60%)
CDW : 89.81 (-1.90%)
COUP : 65.69 (+0.80%)
QTWO : 49.86 (-0.12%)
DENN : 16.69 (-0.06%)
MYL : 30.04 (-1.22%)
DFRG : 6.36 (-4.50%)
GCAP : 7.35 (-1.21%)
FEYE : 18.62 (-4.61%)
MXIM : 53.38 (-1.48%)
POL : 29.49 (-2.09%)
AN : 33.45 (-1.73%)
TWO : 14.22 (+0.35%)
HUBG : 37.20 (-7.44%)
AR : 12.16 (-0.73%)
RE : 217.73 (-1.04%)
NNBR : 6.43 (-7.48%)
ARE : 123.00 (+1.41%)
CVI : 37.02 (-0.54%)
CERS : 5.67 (-1.39%)
NDAQ : 87.02 (-0.54%)
ELLI : 65.02 (-1.95%)
BLDR : 11.16 (-1.50%)
EGRX : 43.11 (-2.75%)
RGLD : 79.56 (+0.39%)
PRGO : 58.51 (-0.59%)
PENN : 22.59 (-1.70%)
NTAP : 62.73 (-3.06%)
IBM : 120.73 (-0.35%)
NTRI : 44.13 (-0.41%)
BANR : 56.87 (-2.12%)
CWT : 48.55 (+1.57%)
STAA : 36.25 (-0.03%)
ATHN : 132.99 (+0.13%)
CL : 65.47 (+0.29%)
TFSL : 15.97 (-1.78%)
UFPI : 26.61 (-0.45%)
SDRL : 11.07 (-8.89%)
GOV : 8.09 (-4.82%)
HQY : 65.72 (-5.70%)
IPGP : 120.20 (-1.72%)
MINI : 32.99 (-4.82%)
CMTL : 25.93 (-0.65%)
CHD : 69.18 (+1.98%)
GPI : 50.06 (-0.95%)
HRL : 45.31 (+0.31%)
RARE : 47.31 (+0.38%)
MLI : 24.03 (-0.21%)
GPS : 26.63 (-3.06%)
CHS : 5.46 (-6.02%)
RYAM : 11.51 (-2.79%)
PBI : 6.85 (-3.52%)
NUVA : 56.15 (-0.83%)
IMDZ : 1.70 (-12.37%)
CAMP : 14.68 (-0.61%)
NOC : 267.85 (-0.84%)
AEL : 29.68 (-0.20%)
EBIX : 45.08 (-0.88%)
DISCA : 27.97 (-1.44%)
GPOR : 9.58 (+1.59%)
BGS : 31.19 (+1.10%)
TECH : 155.67 (-3.90%)
PCH : 34.96 (-0.17%)
NOV : 27.50 (-3.03%)
TECD : 84.66 (-1.68%)
DISCK : 25.99 (-0.23%)
DECK : 122.68 (-3.10%)
NOW : 188.15 (+0.27%)
MGLN : 62.56 (+6.70%)
IEX : 135.01 (-0.44%)
PTC : 86.78 (-0.20%)
AVT : 39.34 (-2.74%)
RGS : 16.24 (-1.52%)
BSFT : 54.95 (+0.09%)
FOSL : 15.99 (-6.00%)
WAL : 40.60 (-2.61%)
IVR : 15.63 (+0.32%)
ENR : 48.88 (+1.92%)
ISBC : 11.21 (-2.69%)
SHOO : 28.90 (-3.22%)
HDP : 16.15 (-1.76%)
AWK : 97.66 (+0.56%)
OMED : 0.79 (-9.20%)
LADR : 17.26 (+0.35%)
BIG : 29.70 (-0.44%)
WY : 24.50 (-0.89%)
JBLU : 17.27 (-2.15%)
GNMK : 4.69 (-2.49%)
FORM : 15.01 (-1.12%)
PFSI : 22.37 (+0.77%)
NEWM : 12.33 (-2.07%)
KFRC : 29.95 (-1.16%)
HOLX : 42.84 (-0.09%)
TMK : 78.02 (-0.67%)
AXTA : 22.64 (-0.70%)
PGEM : 21.65 (unch)
CLH : 55.82 (+0.47%)
CLI : 21.01 (+0.05%)
NRG : 42.68 (+1.11%)
CLGX : 36.98 (-1.86%)
SFLY : 43.16 (-3.70%)
ICUI : 228.58 (-2.53%)
CARA : 14.08 (-9.40%)
WTR : 35.79 (+1.24%)
NTGR : 50.53 (-2.09%)
OLED : 96.45 (-0.63%)
VNDA : 26.15 (-1.62%)
HIBB : 14.36 (-0.90%)
FFBC : 25.67 (-2.13%)
DLTR : 85.05 (+0.56%)
EQT : 20.19 (+1.00%)
OMER : 13.39 (-6.69%)
KTOS : 14.55 (-1.36%)
SRCL : 40.89 (-2.15%)
GES : 19.99 (-8.72%)
KMX : 62.36 (-1.55%)
PLAB : 10.02 (+5.70%)
NCS : 10.36 (-3.18%)
MAR : 108.85 (-1.11%)
MRVL : 15.65 (+1.95%)
UAL : 87.48 (-2.40%)
CNK : 40.47 (+0.42%)
NATH : 67.04 (-2.35%)
TPH : 11.38 (-2.82%)
OCUL : 5.64 (-1.57%)
SKYW : 45.65 (-7.89%)
HIVE : 3.40 (-6.59%)
GAIA : 10.98 (-5.26%)
ESRX : 98.95 (+2.08%)
PHM : 25.81 (-1.30%)
EBS : 62.15 (-3.76%)
CACI : 161.19 (-1.12%)
SAVE : 60.66 (-0.51%)
EZPW : 8.68 (-3.66%)
TPX : 48.67 (-3.62%)
KLAC : 92.68 (-0.92%)
ULTA : 251.52 (-1.42%)
WWE : 73.68 (-0.37%)
ESV : 4.43 (-5.34%)
LTRPA : 18.56 (-2.21%)
DAL : 53.55 (-4.83%)
BMY : 53.64 (+0.37%)
ECL : 155.04 (+0.09%)
CHRW : 84.83 (-3.73%)
WWW : 32.57 (-3.12%)
ETH : 19.04 (-2.61%)
IART : 49.21 (-1.18%)
LE : 13.95 (-2.17%)
LH : 139.71 (-0.81%)
HZO : 19.84 (-0.25%)
MTD : 599.58 (-1.33%)
OSTK : 17.98 (-5.86%)
LDOS : 58.44 (-1.75%)
SAGE : 100.62 (-9.06%)
CIEN : 34.91 (+8.62%)
MTW : 15.50 (-4.02%)
AMC : 14.86 (-2.69%)
NDLS : 7.35 (-4.05%)
EFII : 26.97 (-3.82%)
SIVB : 196.13 (-3.87%)
MU : 35.02 (-2.80%)
DSW : 23.57 (-5.00%)
VRNT : 46.71 (-1.68%)
OII : 14.58 (-4.20%)
SAFM : 100.11 (-0.84%)
DATA : 130.84 (+1.56%)
TLYS : 10.60 (-1.67%)
TREE : 235.43 (-5.22%)
TRUP : 25.72 (-3.89%)
AMCX : 55.99 (-4.96%)
EXPD : 70.81 (-2.01%)
SUPN : 35.60 (-4.30%)
NBIX : 73.01 (-1.11%)
SAIC : 69.67 (-2.90%)
CBM : 42.43 (-2.93%)
BURL : 161.91 (-2.48%)
AMED : 129.60 (-2.39%)
EXPR : 5.55 (-4.64%)
SBH : 18.83 (-2.38%)
ATSG : 17.76 (-2.52%)
PLT : 37.66 (-3.90%)
QDEL : 50.72 (-1.44%)
NLNK : 1.72 (-4.44%)
STMP : 160.76 (-2.74%)
IPCC : 142.80 (+0.32%)
BMTC : 36.10 (-2.54%)
STML : 9.97 (-8.20%)
EGL : 31.24 (-2.83%)
LUV : 50.34 (-1.10%)
CCL : 56.59 (+0.12%)
INOV : 13.96 (+10.79%)
COTY : 7.60 (-1.94%)
MGM : 26.64 (-0.86%)
AKBA : 8.69 (-2.80%)
LGIH : 41.75 (-1.44%)
CDNS : 44.11 (-0.63%)
CRZO : 13.99 (-1.76%)
TEN : 28.20 (-2.89%)
HAIN : 19.20 (+0.42%)
Cerus Supports FDA's Continuing Efforts to Enhance the Safety of the U.S. Platelet Supply

Cerus Corporation (Nasdaq:CERS) announced today the issuance of a new U.S. Food and Drug Administration (FDA) draft guidance document on bacterial risk control strategies for platelet collection...

CERS : 5.67 (-1.39%)
Relatively Good Performance Detected in Shares of Icu Medical in the Health Care Supplies Industry (ICUI , CERS , OSUR , XRAY , HAE )

Here are the top 5 stocks in the Health Care Supplies industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

OSUR : 11.87 (-2.70%)
CERS : 5.67 (-1.39%)
ICUI : 228.58 (-2.53%)
Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Lexicon Pharmaceuticals, Inc....

LXRX : 7.09 (-4.19%)
CRAY : 23.03 (-2.54%)
RICK : 22.19 (-0.76%)
SANM : 24.95 (-2.69%)
DO : 10.91 (-3.54%)
CERS : 5.67 (-1.39%)
Cerus to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Cerus Corporation (Nasdaq:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, and Vivek Jayaraman, Cerus' chief commercial officer, are scheduled...

CERS : 5.67 (-1.39%)
The Global Infection Control Market is Set to Grow as the U.S. Population Ages

According to MarketsandMarkets, the global infection control market is expected to reach USD 21.06 Billion by 2022, after having grown from USD 15.35 Billion in 2017. The market is also expected to have...

CTSO : 8.75 (-1.69%)
MD : 37.53 (-2.01%)
OMI : 6.76 (-1.60%)
CERS : 5.67 (-1.39%)
PCTL : 0.1605 (-5.59%)
Cerus to Present at the 2018 Stephens NY Investment Conference

Cerus Corporation (Nasdaq:CERS) announced today that William 'Obi' Greenman, Cerus' president and chief executive officer, and Kevin Green, Cerus' vice president, finance and chief financial...

CERS : 5.67 (-1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CERS with:

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

2nd Resistance Point 5.86
1st Resistance Point 5.76
Last Price 5.67
1st Support Level 5.60
2nd Support Level 5.53

See More

52-Week High 8.05
Fibonacci 61.8% 6.25
Fibonacci 50% 5.70
Last Price 5.67
Fibonacci 38.2% 5.15
52-Week Low 3.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar